何 美 鄉 教授

Dr. Mei-Shang Ho, Professor

 

Institute of Biomedical Sciences

Academia Sinica

Taipei 11529, Taiwan

Phone: 886 2 2789-9120

Fax: 886 2 2782-3047

E-mail: homs@ibms.sinica.edu.tw

Education Research Publications


Education

 

 University                                   Purdue University

                                                 West Lafayette, Indiana

                                                 B.S.-1976

 

Professional Schools                   Indiana University School of Medicine

                                                 Bloomington & Indianapolis, Indiana

                                                 M.D.-1981

 

                                                 Cambridge University School of Medicine

                                                 Cambridge, United Kingdom

                                                 Exchange Student -1981 (3 months)

 

                                                 Harvard School of Public Health

                                                 Boston, Massachusetts

                                                 M.P.H.-1985

 

Internship                                   Los Angeles County/University of Southern California Medical Center

                                                 Internal Medicine

                                                 Los Angeles, California, 1981-1982

 

Residency                                  Los Angeles County/University of Southern California Medical Center

                                                 Internal Medicine

                                                 Los Angeles, California, 1982-1984

 

Fellowship                                  Los Angeles County/University of Southern California Medical Center

                                                 Communicable Diseases

                                                 Los Angeles, California, 1985-1986

Licensure                                   California Physician's License

                                                 Massachusetts Physician's License

                                                 R.O.C. Physician's License     

          

Board Certification                      American Board of Internal Medicine

 

Board Eligibility                           American Board of Infectious Diseases

                                                 American Board of Preventive Medicine
 

Professional Background:
Appointment:

 

Research Fellow                                                    2006 - present
Associate Research Fellow

Institute of Biomedical Sciences                              1992 - 2006

Academia Sinica

Taipei, Taiwan                                         

 

Adjunct Associate Professor

School of Public Health

National Taiwan University

Taipei, Taiwan                                                       1990 - present    

 

Scientist

Special Task on National Vaccine Policy

National Institute of Preventive Medicine

Taipei, Taiwan                                                      July 1994 - Jan 1995

 
Visiting Scientist

National Science Council                                       1989 - 1992

 

Medical Epidemiologist

Division of Viral Diseases

Center for Infectious Disease

Centers for Disease Control

Atlanta, Georgia, U.S.A.                                          1988-1989

 

Epidemic Intelligence Service Officer

Division of Viral Diseases

Center for Infectious Disease

Centers for Disease Control

Atlanta, Georgia, U.S.A.                                           1986-1988


Services

 

Consultancy & Committees

Temporary consultant,                                                  

World Health Organization                                         1986, 1988-1990

 

Committee member of the Advisory Committee for Immunization Practice,

Department of Health, Taiwan.                                     1990-present

 

Advisor, National Institute of Preventive Medicine

Department of Health, Taiwan.                                      1995-2000

 
Committee member of the Advisory Committee for Infectious disease Control Department of Health, Taiwan., 1998-1999

 

Member of the SARS experts Committee and SARS Control Task Force, Taiwan,  2003
 

Member of Tack Force of Pandemic Influenza Preparedness, Taiwan   2003- present

 

Institutional Committees

-     Chair of the Institutional Review Board, IBMS, 2000-2004

-     Vice chairperson of the Institutional Review Board, Academia Sinica, 2004-6

-     Chairperson of the Institutional Review Board, Academia Sinica, 2006-

Member, Biosafety Committee, Academia Sinica,   2000- 

-     Member, Committee of Human Right, Academia Sinica, 2005-

Grant Reviews

    served as a reviewer to Taiwan-NSC and Taiwan NHRI on a yearly routine basis

    served as a reviewer to a development grant of Pasteur Institute

    served on the review board for development grants of Taiwan-CDC 

    Heads a study session on the epidemiology of influenza research projects

 

Scientific Review –  Journal of Infectious Disease
                             Emerging Infectious Disease

 

Awards & Honors

 

Outstanding Research Award, Executive Yuan, Taiwan                     1994

The Chiron Biocine Award, International Congress for Infectious Diseases   1996

Honorary membership Infectious Disease Society, ROC       1998

Contribution Award in SARS Control, Executive Yuan, Taiwan  2003

Contribution Award in Public Health, Department of Health, Taiwan  2003

 

Teaching & Academic Supervisions:

 

College of Public health, National Taiwan University                         1990 - present

                       (1) Vaccinology (graduate course)                           Alternate year

                       (2) Data-based Decision Making in Infectious Disease Control:

                                case studies  (graduate course)                Alternate year

Clinical Instructor, Communicable Diseases,

University of Southern California, School of Medicine                        1985-1986

 

Associate Instructor of Anatomy, Indiana University                          Spring, 1979

Undergraduate Teaching Assistant of Biology, Purdue University               Fall, 1975

 



Research

 

Publications

1. Rabkin, CS, E Telzak, M-S Ho, J Goldstein, Y Bolton, M Pallansch, L Anderson, E Kilchevsky, S. Solomon, W.J. Martone. Outbreak of Echovirus, 11 infection in hospitalized neonates. Pediatric Infectious Disease Journal, 7(3):186-90, 1988.

 

2. M-S Ho, RI Glass, PF Pinsky, LJ Anderson. Rotavirus as a cause of diarrhea morbidity and mortality in the United States. Journal of Infectious Diseases, 158(5):1112-6, 1988.

 

3. M-S Ho, RI Glass, PF Pinsky, N Young-Okoh, WM Sapendield, JW Buehler, N Gunter, L.J. Anderson. Diarrheal deaths in American children: Are they preventable? JAMA. Journal American Medicine Association, 260(22):3281-5, 1988.

 

4. M-S Ho, Floyd LR, Glass RI, Pallansch MA, Jones B, Woods P, Penaranda ME, Kapikian AZ, Bohan G, Wilcox WD, Blumberg R. Simultaneous administration of rhesus rotavirus vaccine (RRV) and oral polio vaccine (OPV): immunogenicity. Pediatric Infectious Disease Journal, 8(10):692-6, 1989.

 

5. Penaranda ME, M-S Ho, Fang Z-Y, Dong H, Wen L, Sheng BX, Duan CS, Ye WW, Estes MK, Qionziu K, Echeverria P, Maung K, Hung T, Glass RI. Seroepidemiology of adult diarrhea rotavirus in  China, 1970 to 1978. Journal of Clinical Microbiology, 27(10):2180-3, 1989.

 

6. M-S Ho, Glass RI, Monroe SS, Madore HP, Stine S, Pinsky PF, Cubitt D, Ashley C, Caul OE. Viral gastroenteritis aboard a cruise ship. Lancet 2(8669):961-4 Oct. 1989.

 

7. Fang Z-Y, Ye Q, M-S Ho, Dong H, Qing S, Penaranda ME, Hung T, Wen L, Glass RI. Investigation of an outbreak of adult diarrhea rotavirus (ADRV) in China. Journal Infectious Diseases 160(6): 948-53, 1989.

 

8. Cook SM, RI Glass, CW LeBaron, and  M-S Ho. Global seasonality of rotavirus infections. Bulletin of the World Health Organization, 6892):171-7,1990.

 

9. Gordon, SM, LS Oshiro, WR Jarvis, D Donenfeld, M-S Ho, F Taylor,  HB Greenberg, RI Glass, HP Madore, R Dolin, and O Tablan. Foodborne snow mountain agent gastroenteritis with secondary person-to-person spread in a retirement community. American Journal of Epidemiology, 131(4):702-10,1990.

 

10. Gouvea V, M-S Ho, R Glass, P Woods, B Forrester, C Robinson, R Ashley, RT Marie, HF Clark, K Taniguchi, E Meddix, B McKellar, and L Pickering.  Serotypes and Electropherotypes of Human Rotavirus in the United States. Journal of Infectious Diseases, 162(2):362-7, 1990.

 

11. Glass RI, JF Lew, RE Gangarosa, CW LeBaron, and M-S Ho. Estimates of Morbidity and Mortality Rates for Diarrheal Diseases in American children. Journal of Pediatrics, 118[4(Pt2)]: S27-33,1991.

  

12.  Lee M-S, C-C King, J-Y Lean, C-L Kao, C-C Wang, M-S Ho, C-J Chen, C-Y Lee. Seroepidemiology and Evaluation of Passive Surveillance during 1988-1989 Measles Outbreak in Taiwan. International Journal of Epidemiology. 21(6):1165-74, 1992.

 

13.  Ko YC, M-S Ho, TA Chiang, SJ Lan, and PY Chang. Tattooing as a Risk of Hepatitis C Virus Infection. Journal of Medical Virology, 38(4):288-91, 1992.

 

14.  Huang CS, M-S Ho, CS Yang, CL Lee, CA Tan. Hepatitis C Markers in Hemodialysis Patients. Journal of Clinical Microbiology 31(7):1764-9,1993. 

 

15.  Shen C-Y, M-S Ho, S-F Chang, M-S Yen, H-T Ng, E-S Huang, C-W Wu, High rate of concurrent genital infections with human cytomalovirus and human papillomavirus in cervical cancer patients. Journal of Infectious Diseases, 168(2):449-52,1993.

 

16.  Tsai J-F, W-Y Chang, J-E Jeng, M-S Ho, L-Y Wang, M-Y Hsieh, S-C Chen, W-L Chuang, Z-Y Lin, J-H Tsai. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. Journal of Medical Virology, 41(4):296-300, 1993.

 

17.  Knoebel, HH., W-S Yang, M-S Ho,  Urban-rural and regional differences in infant mortality in Taiwan. Social Science & Medicine, 39(6):815-22, 1994.

 

18.  Tsai J-F, J-F Jeng, M-S Ho, W-Y Chang, Z-Y Lin, J-H Tsai. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. International Journal of Cancer, 56(5):619-21, 1994.

 

19.  M-S Ho, R-Z Lewanczuk, B-H Teh, S-C Lee, P K-T Pang. Parathyroid hypertensive factor and non-insulin-dependent diabetes mellitus. Journal of Cardiovascular Pharmacology,

甲、23(Suppl 2):S31-4, 1994.

 

20.  Tsai J-F, W-Y Chang, M-S Ho, J-E Jeng, Z-Y Lin, J-H Tsai. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver, 14(2):98-102, 1994.

 

21.  Tsai J-F, W-Y Chang, M-S Ho, Z-Y Lin, J-H Tsai. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. Journal of Medical Virology, 44(1):92-5, 1994.

 

22.  M-S Ho, C-S Yang, P-J Chen, Y-C Mau. Intrafamilial transmission of hepatitis C virus. Journal of Clinical Microbiology, 32(11);11:2824-6, 1994.

 

23.  Tsai J-F, W-Y Chang, J-E Jeng, M-S Ho, Z-Y Lin, J-H Tsai. Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. British Journal of Cancer , 69(6):1157-9, 1994.

 

24.  Tsai J-F, HS Margolis, J-E Jeng, M-S Ho, Y-C Ko, Z-Y Lin, W-Y Chang, J-H Tsai. Association between hepatitis B and C virus infection and Chinese hepatocellular carcinoma: a case-control study. Viral Hepatitis and Liver Disease, 697-700, 1994.

 

25.  R-Z Lewanczuk, L-M Resnick, M-S Ho, C-G Benishin, Jie Shan, P K-T Pang. Clinical aspects of parathyroid hypertensive factor. Journal of Hypertension, 12(suppl 1): S11-16, 1994.

 

26.  Lee M-S, C-C King, C-J Chen, S-Y Yang, M-S Ho. Epidemiology of measles in Taiwan: dynamics of transmission and timeliness of reporting during an epidemic in 1988-9. Epidemiology and Infection, 114(2);345-59, 1995.

 

27.  Tsai J-F, J-E Jeng, W-Y Chang, M-S Ho, Z-Y Lin, J-H Tsai. Increased IgM-containing circulating immune complexes in patients co-infected with Hepatitis C and Hepatitis B. Medicine, 74(3);136-143, 1995.

 

28.  Tsai J-F, H-S Margolis, J-E Jeng. M-S Ho, W-Y Chang, Z-Y Lin, J-H Tsai. Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clinical Immunology and Immunopathology, 75(1):39-44, 1995.

 

29.  Yang S-S, C-H Wu, C-S Huang, M-S Ho, M-Y Lai, J-H Kao, D-S Chen. Early interferon therapy and abortion of possttransfusion hepatitis C viral infection. Journal of Clinical Gastroenterology, 21(1):38-41, 1995.

 

30.  Tsai J-F, J-E Jeng, M-S Ho, W-Y Chang, Z-Y Lin, J-H Tsai. Clinical evaluation of serum a-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma. British Journal of Cancer, 72(2):442-6, 1995.

 

31.  Tsai J-F. J-E Jeng, W-Y Chang, M-S Ho, Z-Y Lin, J-H Tsai. Circulating immune complexes in chronic hepatitis C. Journal of Medical Virology 46(1):12-7, 1995.

 

32.  M-S Ho, C-F Lu, Jean Kuo, Y-C Mau, W-H Chao. A family cluster of an immune escape variant of hepatitis B virus infecting a mother and her two fully immunized children. Clinical & Diagnostic Laboratory Immunology. 2(6):760-2, 1995.

 

33.  Hsu L-C, S-R Lin, H-M Hsu, W-H Chao, J-T Hsieh M-C Wang, C-F Lu, Y-H Chang, M-S Ho. Ethnic differences in immune responses to hepatitis B vaccine. American Journal of Epidemiology. 143(7):718-24, 1996.

 

34.  Tsai J-F, J-E Jeng, M-S Ho, W-Y Chang, Z-Y Lin, J-H Tsai. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. Journal of Hepatology, 24(3): 271-6, 1996.

 

35.  Tsai J-F, J-E Jeng, M-S Ho, W-Y Chang, M-Y Hsieh, Z-Y Lin, J-H Tsai.  Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. British Journal of Cancer, 73(12):1498-502, 1996.

 

36.  Tsai J-F, HS Margolis, J-E Jeng, M-S Ho, W-Y Chang, M-Y Hsieh, Z-Y Lin, J-H Tsai. Increased IgM class circulating immune complexes in a acute hepatitis virus infection.  Clinical Immunology & Immunopathology, 78(3): 291-5, 1996.

 

37.  Glass RI, PE Kilgore, RC Holman, S Jin, JC Smith, PA Woods, MJ Clarke, M-S Ho, JR Gentsch. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. Journal of Infectious Diseases, 174(Suppl 1): S5-11, 1996.

 

38.  J-F Tsai, H-S Margolis, J-E Jeng, M-S Ho, W-Y Chang, M-Y Hsieh, Z-Y Lin, J-H Tsai. Hepatitis B surface antigen- and immunoglobulin-specific circulating immune complexes in acute hepatitis B virus infection. Clinical Immunology and Immunopathology, Article No.0124, 80(3 Pt 1):278-282, 1996.

 

39.  J-F Tsai, J-E Jeng, L-Y Chuang, M-L Yang, M-S Ho, W-Y Chang, M-Y Hsieh, Z-Y Lin,  J-H Tsai. Clinical evaluation of urinary transforming growth factor-betal and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma. British Journal of Cancer, 75(10):1460-1466, 1997. 

 

40.  J-F Tsai, J-E Jeng, L-Y Chuang, M-L Yang, M-S Ho, W-Y Chang, M-Y Hsieh, Z-Y Lin,  J-H Tsai. Elevated urinary transforming growth factor-betal level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. British Journal of Cancer, 76(2):244-250, 1997.

 

41.  M-S Ho, C-P Hsu, Y Yuh, C-C King, J-F Tsai, Y-C Mau, L-C Hsu, W-H Chao. High rate of hepatitis C virus infection in an isolated community: persistent  hyperendemicity or  period-related phenomena?  Journal of Medical Virology, 52(4): 370-376, 1997.

 

42.  J-F Tsai, J-E Jeng, M-S Ho, W-Y Chang, M-Y Hsieh, Z-Y Ln, J-H Tsai. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a  prospective study. British Journal of Cancer, 76(7):968-974, 1997.

 

43.  H-L Chiou, T-S Lee, J Kuo, Y-C Mau, M-S Ho. Altered antigenicity of “a” determinant variants of hepatitis B virus.  Journal of General Virology, 78(10): 2639-2645, 1997.

 

44.  J-F Tsai, J-E Jeng, M-S Ho, C-S Wang, W-Y Chang, M-Y Hsieh, Z-Y Lin, J-H Tsai. Serum alanine aminotransferase level in relation to hepatitis B and C virus infections  among blood donors. Liver, 17(1): 24-29, 1997.

 

45.  L-C Hsu, Y-C Wu, S-R Lin, C-C King, M-S Ho, C-F Lu, H-M Hsu, K-T Chen,  C-B Horng. Seroepidemiology of Japanese encephalitis viral infection among 3-6 years old  children from mountainous and plains townships located in the northern, central, southern  and eastern Taiwan. Chinese Journal Microbiol Immunol. 30: 194-206, 1997. 臺灣北中南東四區山地和平地鄉 3-6 歲兒童日本腦炎病毒感染的血清流行病學研究

 

46.  M-S Ho, Y-C Mau, C-F Lu, S-F Huang, L-C Hsu, S-R Lin, H-M Hsu. Patterns of  circulating hepatitis B surface antigen variants among vaccinated children born to  hepatitis B surface antigen carrier and non-carrier mothers. Journal of Biomedical  Science, 5: 355-362, 1998.       

 

47.  J-F Tsai, H-S Margolis, J-E Jeng, M-S Ho, W-Y Chang, M-Y Hsieh, Z-Y Lin, J-H Tsai. Immunoglobulin-and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection. Clinical Immunology & Immunopathology, 86(3): 246-51, 1998.   

 

48.  D-E Schuback, E-L Mulligan, K-B Sims, E-A Tivol, B-D Greenberg, S-F Chang, S-L Yang, Y-C Mau, C-Y Shen, M-S Ho, N-H Yang, M-G Butler, C-E Schwartz, F Berlin, X-O Breakefield, D-L Murphy, Y-P Hsu. Screen for MAOA mutations intarget human groups. American Journal of Medical Genetics, 88(1): 25-28, 1999.    

 

49.  D-B Lin, W-T Nieh, H-M Wang, M-W Hsiao, U-P Ling, S-P Changlai, M-S Ho, S-L You, C-J Chen. Seroepidemiology of helicobacter pylori infection among preschool children in Taiwan. American Journal of Tropical Medicine and Hygiene, 61(4): 554-558, 1999.  

 

50.  Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho M-S, Lin SH, Chen CJ. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. Journal of Medical Virology, 59(3):290-6, 1999.  

 

51.  J-F Tsai, L-Y Chuang, J-E Jeng, M-S Ho, Z-Y Lin, M-Y Hsieh, Y-L Wang, J-H Tsai. Sex differences in relation to serum hepatitis B e antigen and alanine aminotransferase levels among asymptomatic hepatitis B surface antigen carriers. Journal Gastroenterology. 35(9): 690-5, 2000.  

 

52.  S-R Shih, M-S Ho, K-H Lin, S-L Wu, Y-T Chen, C-N Wu, T-Y Lin, L-Y Chang, K-C Tsao, H-C Ning, P-Y Chang, S-M Jung, C Hsueh, K-S Chang. Genetic analysis of  enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Research, 68: 127-136, 2000.    

 

53. Lin DB, Tsai TP, Yang CC, Wang HM, Nieh WT, Ling UP, Changlai SP, You SL, Ho M-S,  Chen CJ. Association between seropositivity of antibodies against hepatitis a virus and  Helicobacter pylori. American Journal of Tropical Medicine and Hygiene, 63(3-4):189- 91, 2000.   

 

54. M-L Huang, L-Y Chiu, W-H Pan, C-M Yang, C-Y Hu, D-B Lin, Cathy SJ Fann, M-S Ho.  Negative association between HLA-A2 and a low antibody response to hepatitis B vaccine  in Bunun ethnic children. Journal of Genetics and Molecular Biology, 12(3): 151-160, 2001.

 

55. J-F Tsai, L-Y Chuang, J-E Jeng, M-S Ho, M-Y Hsieh, Z-Y Lin, L-Y Wang. Betel quid  chewing as a risk factor for hepatocellular carcinoma: a case-control study. British Journal of  Cancer. 84(5): 709-13, 2001.    

 

56. C-N Wu, Y-C Lin, Cathy Fann, N-S Liao, S-R Shih, M-S Ho. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1  vaccines and inactivated virus. Vaccine, 20(5-6): 895-904, 2002.    

 

57. Y-C Lin, C-N Wu, S-R Shih, M-S Ho. Characterization of a vero cell-adapted virulent  strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine, 7;20(19-20):2485- 2493, 2002.    

 

58. T-Y Lin, S-J Twu, M-S Ho, L-Y Chang, C-Y Lee. Enterovirus 71 outbreak, Taiwan: occurrence and recognition. Emerging Infectious diseases, 9(3): 291-3, 2003.        

 

59. Hu Y-C, Hsu JTA, Huang J-H, Ho M-S, Ho Y-C. Formation of enterovirus-like particle  aggregates by recombinant baculovirusesco-expressing P1 and 3CD in insect cells. Biotechnology Letters 25 (12): 919-925 Jun 2003. 

 

60. Tsai JF, Jeng JE, Chuang LY, Ho M-S, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Ho C. Habitual betel quid chewing as a risk factor for cirrhosis  A case-control study. Medicine (Baltimore), 82 (5): 365-372 Sep 2003.    

 

61. Tsai JF, Jeng JE, Chuang LY, You HL, Ho M-S, Lai CS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY. Serum insulin-like growth factor-II and alpha- fetoprotein as tumor markers of hepatocellular carcinoma. Tumor Biology, 24(6):291-8, 2003.

 

62. Shih SR, Chiang C, Chen TC, Wu CN, Hsu JT, Lee JC, Hwang MJ, Li ML, Chen GW,  Ho M-S. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its  RNA binding and proteolytic activities. Journal of Biomedical Science, 11(2):239-48, 2004.

 63. Tsai JF, Jeng JE, Chuang LY, Ho M-S, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY. Habitual betel quid chewing
      and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore). 83(3):176-87, May, 2004.

64. Dowell SF, Simmerman JM, Erdman DD, Wu JS, Chaovavanich A, Javadi M, Yang JY, Anderson LJ, Tong S, Ho M-S. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clinical Infectious Diseases, 39(5):652-7, Sep 1, 2004; Epub 2004 Aug 11.

 65.  Hsueh PR, Kao CL, Lee CN, Chen LK, Ho M-S, Sia C, Fang XD, Lynn S, Chang TY, Liu SK, Walfield AM, Wang CY. SARS antibody test for
       serosurveillance. Emerging Infectious Disease. 10(9):1558-62, Sep, 2004.

 66.  Lan Y-C,  Liu T-T,  Yang J-Y,  Lee C-M. Chen Y-J,  Chan Y-J,  Lu J-J, Liu H-F, Hsiung C A,  Ho M-S, Hsiao K-J,  Chen H-Y,  and Chen Y-M A.,  Molecular
       Epidemiology of SARS Coronavirus Infections in Taiwan. Journal of Infectious Diseases. Journal Infectious Diseases, 191(9) : 1478-89, May, 2005.  

 67. Shu PY, Chien LJ, Chang SF, Su CL, Kuo YC, Liao TL, Ho M-S, Lin TH, Huang JH. Fever screening at airports and imported dengue. Emerging Infect
      Disease. 11(3):460-2, Mar, 2005.  

 68.  Hsieh YH, King CC, Chen CW, Ho M-S, Lee JY, Liu FC, Wu YC, JulianWu JS. Quarantine for SARS, Taiwan. Emerging Infect Disease. 11(2):278-82, Feb,
       2005. 

69.  Yen MY, Lin YE, Su IJ, Huang FY, Huang FY, Ho MS, Chang SC, Tan KH, Chen KT, Chang H, Liu YC, Loh CH, Wang LS, Lee CH.Using an integrated infection control strategy during outbreak control to minimize nosocomial infection of severe acute respiratory syndrome among healthcare workers. J Hosp Infect. 2006 Feb;62(2):195-9. Epub 2005 Sep 8.

70.  Ho M-S, Chen W-J, Chen H-Y, Lin S-F, Wang M-C, Di J, Lu Y-T, Liu C-L, Chang S-C, Chao C-L, King C-C, Chiou J-M, Su I-J, Yang J-Y. Neutralizing Antibody
      Response and the Severity of SARS. Emerging Infect Dis. 11(11):1730-7. Nov 2005.

 71. Yang YY, Huang CF, Wei JCC, Ho M-S, Wang Lina, Lin SJ, Tsai WY, Lin CC, Xu F. Yang CC.  The Study of IgG Subclass Profiles of Anti-HBc in Populations
       with Different Status of HBV Infection. Cellular & Molecular Immunology. 3(5):393-8, 2005

72.  Ho M-S.  I thinkI got "That Disease": An interview with a medical student who had recovered from SARS in Guangzhou, China. Public Health. 120(1):6-7. 2006
      Jan   

 73. Tsai T-H, Huang C-F, Wei J C-C, Ho M-S, Wang L, Tsai W-Y, Lin C-C, Xu F-L, Yan C-C. The study of IgG subclass profiles of anti-HBs in populations with  
      different status of HBV infection. Viral Immunol. (accepted) 2006.

 74. Chen YM, Liang SY, Shih YP, Chen CY, Lee YM, Chang L, Jung SY, Ho MS, Liang KY, Chen HY, Chan YJ, Chu DC. Epidemiological and genetic correlates
      of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol. 2006  
      Feb;44(2):359-65.

 75. Chen W-J, Yang J-Y,  Lin J-H, Fann C S-J,1  Osyetrov V, King C-C, Chen Y-M A, Chang H-L, Kuo H-W, Liao F, Ho M-S. Nasopharyngeal Shedding of Severe
      Acute Respiratory Syndrome-Associated Virus (SARS-CoV) is Associated with Genetic Polymorphisms. Clin Infect Dis. 2006 Jun 1;42(11):1561-9. 

 76. Pan,W-H, Fann,C.S.J., Wu,J-Y, Hung,Y-T; Ho, M-S, Tai,TH, Chen,Y-J, Liao,C-J, Yang, M-L; Cheng, AT-A; Chen,Y-T; Han Chinese Cell and Genome Bank in
      Taiwan: Purpose, Design and Ethical Considerations Hum Hered 2006;61:27-30.

 77. Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho M-S, Hu YC. Expression, purification and characterization of enterovirus-71 virus-like particles. World
      J Gastroenterol. 2006 Feb 14;12(6):921-7.

 78. Chou C-C, Lee T-T, Chen C-H, Hsiao H-Y, Lin Y-L, Ho M-S, Yang P-C, Peck K. Design of microarray probes for virus identification and detection of emerging
       viruses at the genus level. BMC Bioinformatics. 2006 Apr 28;7(1):232.

Reviews &  Invited Commentary

 

1.Y-P Yeh, K-L Hwang, S-T Hsu, T-N Wu, D-Y Chao, P-I Lee, M-S Ho. Overview of the epidemic of enterovirus Infection in Taiwan, 1998. Formosan Journal of Medicine, Vol.3, No.1:057-61, January, 1999. 1998年台灣腸病毒疫情綜論, 台灣醫學會雜誌。

 

2. 何美鄉. 新興傳染病所需的防疫體系。中華衛誌,Vol.17No.3P171-1721998  [Reinventing the public health infrastructure to confront emerging infection diseases]     Chinese Journal of Public Health (Taipei), Vol.17, No.3, P171-172, 1998.

 

3. T-Y Lin, S-J Twu, M-S Ho, L-Y Chang, C-Y Lee. Enterovirus 71 outbreak, Taiwan: occurrence and recognition. Emerging Infectious diseases, 9(3): 291-3, 2003. 

 

4.  Ho M-S, SuIJ. Preparing to prevent severe acute respiratory syndrome and other respiratory infections. Lancet Infectious Disease, 4(11):684-9, Nov, 2004. (Invited review article)

 

5. Dowell SF, Ho M-S. Seasonality of infectious disease and severe acute respiratory syndrome-what we don’t know can hurt us. Lancet Infectious Disease, 4(11):704-8, Nov, 2004. (Review article)

 

 

Chapter:

 

 1. Hegeman S, M-S Ho, M Bay, LV Beck. Effects in mice of orchidectomy and Flutamide on Hypothalamic luteinizing hormone and seminal vesicle weights. The Anterior Pituitar Gland,  pp184-93, Aven Press, New York, 1983.

 

 2. R-I Glass, M-S Ho, Judy Lew, C-W LeBaron, Donna Lng. Cost-Benefit studies of rotavirus vaccines in the United States. SAREC Conference Report 1990:2 pp102-107.

 

 3. Tsai J-F, H-S Margoles, J-E Jeng, M-S Ho, Y-C Ko, Z-Y Lin, W-Y Chang, J-H Tsai. Association between hepatitis B and C virus infection and Chinese hepatocellular carcinoma: a case-control study. Viral Hepatitis and Liver Disease pp697-700, by Springer-Verlag Tokyo, 1994.

 

Invitational Presentations

 

Symposia 

1. Pathogenesis of Enterovirus 71, Annual meeting of Taiwan Medical Association, Taipei, Taiwan, 1999

2. Virus-Host Interaction: Enterovirus 71. Plenary Session Asian Pacific Organization of Cell Biology, Taipei, Taiwan, Nov 2003 

3. The Epidemiology of Acute Respiratory Syndrome. Annual Meeting of Taiwan Cancer Society, Taipei, Taiwan, June 2003

4. The Epidemiology and Control of SARS, International Symposium on Confronting with SARS and Influenza. Milan, Italy, Nov. 2003

5. Focus Session, ICCAC, Washington, DC, Nov, 2004

 

Institutions

1. Hemorrhagic pulmonary shock syndrome in association with an outbreak of enterovirus 71, National Cheng Kong (成功) University, 1998

2. Hemorrhagic pulmonary shock syndrome in association with an outbreak of enterovirus 71. Pasteur Institute, Nov , 1999

3. National Research Institute of Health,  Tenth Anniversary Symposium, April 18, 2005



Members of Laboratory
 

Post-doctoral Fellows

1.  Hui-Ling Chiou, Assistant Professor, Chung Shan Medical College

2.  Ya-Ching Lin, Assistant Professor, Ping-Tung Institute of Technology

3.  Ting-Hui Wong, Scientist, Pharmaceutics.

 

PhD.  Students

1. Cheng Nan Wu,  Assistant professor, Chung Tai Institute of Technology